NPAF Applauds Cancer Moonshot; Requests Congress Fully Fund Initiative
2016-04-13 | April 13, 2016
(Washington, DC) Citing the 595,000 Americans who will die from cancer in 2016, along with the $216 billion cancer costs the U.S. economy, the National Patient Advocate Foundation praised President Obama’s National Cancer Moonshot and called upon Congress to fully fund the initiative.
“While many organizations have called for a large national focus on cancer research, this is the first time such a call has come from the President. We applaud not only the grandness of his vision, but also its practical scope, which will set the stage for real change for cancer patients in the decades to come,” said Alan Balch, PhD, NPAF CEO.
NPAF called upon Congress to support a $2.4 billion increase for the National Institutes of Health (NIH). In light of the Moonshot initiative, NPAF urged Congress to prioritize funding for the National Cancer Institute (NCI), the federal government’s principal agency for cancer research and training.
NPAF also placed critical importance on increased funding for the Food and Drug Administration, citing the need to accelerate the pace of medical discovery and ensure that safe, breakthrough drugs can be used by the patients who need them as quickly as possible.
NPAF has long advocated for increased funding for medical research and regulatory science through initiatives like Project Innovation, and through coalitions like One Voice Against Cancer (OVAC). Through OVAC, NPAF endorsed the following funding recommendations:
- National Institutes of Health – $34.5 billion, including:
- National Cancer Institute – $5.9 billion
- National Institute on Minority Health and Health Disparities – $301 million
- National Institute on Nursing Research – $157 million
- Centers for Disease Control and Prevention cancer programs – $514 million, including:
- National Comprehensive Cancer Control Program: $50 million
- National Program of Cancer Registries: $65 million
- National Breast and Cervical Cancer Early Detection Program: $275 million
- Colorectal Cancer Control Program: $70 million
- National Skin Cancer Prevention Education Program: $5 million
- Prostate Cancer Awareness Campaign: $35 million
- Ovarian Cancer Control Initiative: $7.5 million
- Gynecologic Cancer and Education and Awareness (Johanna’s Law): $5.5 million
- Cancer Survivorship Resource Center: $900,000
- Health Resources and Services Administration (HRSA)
- Title VIII Nursing Programs: $244 million
- Food and Drug Administration (FDA) – $2.9 billion
According to the White House, the National Cancer Moonshot will work to accelerate cancer research and to break down barriers to progress by enhancing data access, and facilitating collaborations with researchers, doctors, philanthropies, patients, advocates, and biotechnology and pharmaceutical companies. The initiative aims to bring about a decade’s worth of advances in five years, making more therapies available to more patents, while also improving our ability to prevent cancer and detect it at an early age.